glp-1 and bowel obstruction Association of receptor agonists with risk of intestinal in patients with type 2 diabetes mellitus: a retrospective cohort study | Acta Diabetologica Weighing the Risks: Small Bowel

Prescription trends show particularly rapid growth for newer agents

doi:10.1016/0003-3472(78)90094-5

Many things affect how well a medication works, including diet, activity level, dose, and how your body responds

The compound remains detectable in urine for up to 4 days by mass spectrometry methods, despite its short plasma half-life, suggesting tissue distribution and binding may extend its biological effects beyond plasma clearance times

However, specific patient populations such as individuals with mutations in their glutathione synthesizing enzymes, AIDS patients, and cystic fibrosis patients can benefit from glutathione supplementation (Ashley, 2018)